Table 3 The relative pair‐wise within‐person variation s¯r, and the relative limit of longitudinal decline LLDr for individuals with asthma and with COPD by quartiles of bronchial hypereactivity (BHR).
| Program | Condition | %ΔFEV1 (n) | s¯r (%) | LLDr (%) | 95th percentile %ΔFEV1 |
|---|---|---|---|---|---|
| P1 | Asthma | 83 | 5.2 | 12.8 | 11.6 |
| P4 | COPD & BHRq1† | 7112 | 7.3 | 17.9 | 18.9 |
| P4 | COPD & BHRq2 | 6575 | 5.8 | 14.6 | 15.3 |
| P4 | COPD & BHRq3 | 8830 | 4.9 | 12.3 | 12.2 |
| P4 | COPD & BHRq4 | 2925 | 4.3 | 10.9 | 10.5 |
†BHRq1‐q4 represent quartiles of BHR; q1 is highest and q4 is lowest degree of BHR.